Drug intelligence / Profile preview

chondroitin sulfate-iron colloid

Development stage
Phase 4
Lead developer
NIPRO
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

**Chondroitin sulfate-iron colloid** is an intravenous colloidal ferric-iron preparation in which iron colloid is stabilized by chondroitin sulfate. It was marketed in Japan as **Blutal** for treatment of iron deficiency anemia, including use as parenteral iron support in hemodialysis-associated anemia. The colloid delivers iron for utilization in hemoglobin synthesis and replenishment of iron stores. Its paramagnetic ferric iron and preferential uptake by the hepatic reticuloendothelial system, including Kupffer cells, also enabled investigational use as an MRI contrast agent for liver lesion and hepatocellular carcinoma imaging. Blutal was subject to a Japanese Class II recall in July 2006 following increased reports of drug eruptions after a change in the chondroitin sulfate raw-material source.

Brand names
Blutal
Other names
chondroitin sulfate and iron colloidchondroitin sulphate iron colloidCSICCSICSFe

Beyond the preview

Go deeper on chondroitin sulfate-iron colloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chondroitin sulfate-iron colloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call